Mikael Dolsten's Net Worth

$41.6 Million

Estimate Recalculated Nov 7, 2024 12:13PM EST

Who is Mikael Dolsten?

Mikael Dolsten has an estimated net worth of $41.6 Million. This is based on reported shares across multiple companies, which include AGILENT TECHNOLOGIES, INC., PFIZER INC, Karyopharm Therapeutics Inc., and WYETH.

SEC CIK

Mikael Dolsten's CIK is 0001437590

Past Insider Trading and Trends

2013 was Mikael Dolsten's most active year for acquiring shares with 25 total transactions. Mikael Dolsten's most active month to acquire stocks was the month of January. 2018 was Mikael Dolsten's most active year for disposing of shares, totalling 25 transactions. Mikael Dolsten's most active month to dispose stocks was the month of January. 2018 saw Mikael Dolsten paying a total of $13,178,071.52 for 922,394 shares, this is the most they've acquired in one year. In 2018 Mikael Dolsten cashed out on 1,215,621 shares for a total of $27,251,571.38, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AGILENT TECHNOLOGIES, INC. (A) Snapshot price: $137.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+41.60%
1.68K
$147.48
$247,471.44
5.71K
Mar 15
Form 4
+70.25%
1.66K
$136.82
$226,847.56
4.02K
Mar 16
Form 4
+314.57%
1.78K
$136.82
$244,223.70
2.35K
Mar 17
Form 4
∞
567
$172.44
$97,773.48
567
Sep 22
Form 3
—
0
—
—
0
No matching records found

PFIZER INC (PFE) Snapshot price: $28.5196

President R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 12
Form 4
-6.25%
-21.44K
$27.04
-$579,656.48
321.73K
Feb 28
Form 4
—
0
—
—
0
Feb 27
Form 4
-6.75%
-24.82K
$27.76
-$689,058.72
343.17K
Feb 23
Form 4
—
0
—
—
0
Dec 15
Form 4
-9.48%
-37.08K
$41.75
-$1,548,006.50
354.14K
Feb 25
Form 4
-7.69%
-32.59K
$42.38
-$1,381,248.96
391.22K
Feb 22 - Feb 23
Form 4
+23.21%
79.11K
$33.21
$2,627,260.16
420.01K
Nov 7
Form 4
-16.09%
-63.90K
$49.32
-$3,151,547.14
333.34K
May 11
Form 4
+34.84%
102.46K
$31.83
$3,261,036.46
396.58K
Mar 3
Form 4
-9.18%
-29.74K
$47.72
-$1,419,383.68
294.12K
Feb 26
Form 4
-8.42%
-29.77K
$46.87
-$1,395,179.29
323.86K
Feb 23 - Feb 24
Form 4
+25.38%
71.19K
$30.17
$2,147,711.79
351.64K
Dec 17
Form 4
+99.95%
139.88K
$37.71
$2,014,279.37
279.84K
Nov 11
Form 4
-14.76%
-23.84K
$33.49
-$798,435.09
137.73K
Feb 27
Form 4/A
-14.89%
-28.27K
$33.82
-$956,125.22
161.57K
Feb 25
Form 4
-15.29%
-28.27K
$33.82
-$956,125.22
156.57K
Feb 25
Form 4
-35.28%
-95.35K
$37.78
-$3,602,681.05
174.92K
May 18
Form 4
-12.81%
-39.45K
$33.42
-$1,318,285.32
268.51K
Feb 28
Form 4
+2.59%
7.77K
$34.72
-$1,312,138.24
307.96K
Feb 26 - Feb 27
Form 4
-13.04%
-43.36K
$37.45
-$3,185,087.35
289.13K
Mar 1 - Mar 4
Form 4
+7.23%
22.41K
$42.93
-$3,167,074.89
332.49K
Feb 27 - Feb 28
Form 4
-14.96%
-54.57K
$42.96
-$2,344,241.28
310.08K
Feb 23
Form 4
+53.36%
125.97K
$29.78
$3,751,424.58
362.05K
Jan 31
Form 4
+345.55%
181.71K
$24.56
$4,462,166.56
234.3K
Sep 13
Form 4
—
0
—
—
0
Aug 13
Form 4
-57.66%
-69.70K
$36.59
-$2,550,393.54
51.19K
Mar 9
Form 4
-10.37%
-13.99K
$35.85
-$501,398.10
120.88K
Mar 2
Form 4
+41.80%
39.76K
$31.61
-$255,306.06
134.87K
Feb 28
Form 4
-17.84%
-20.66K
$37.06
-$3,955,916.49
95.11K
Feb 26 - Feb 27
Form 4
+126.19%
64.59K
$27.51
-$664,532.96
115.77K
Feb 23 - Feb 24
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Jun 16
Form 4
-38.57%
-30.97K
$34.51
-$1,068,923.67
49.32K
Mar 1 - Mar 2
Form 4
-42.78%
-60.03K
$34.27
-$3,146,832.77
80.29K
Feb 27
Form 4
+72.23%
58.85K
$27.03
-$675,990.82
140.31K
Feb 23
Form 4
—
0
—
—
0
Nov 14
Form 4
-15.42%
-67.59K
$33.46
-$2,261,564.19
370.62K
May 4
Form 4
+2.11%
8.98K
$30.23
-$288,666.27
435.21K
Feb 28
Form 4
+15.94%
58.61K
$24.35
-$544,203.41
426.23K
Feb 24 - Feb 25
Form 4
-14.07%
-58.30K
$34.46
-$2,009,152.29
355.91K
Mar 5
Form 4
+16.38%
58.3K
$25.87
-$1,192,465.92
414.21K
Feb 25 - Feb 26
Form 4
—
0
—
—
0
Jan 13
Form 4
—
0
—
—
0
Oct 10
Form 4
—
0
—
—
0
Jul 11
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Mar 14
Form 4
-9.41%
-35.79K
$32.58
-$1,165,928.62
344.57K
Mar 4
Form 4
+20.50%
64.7K
$31.99
-$921,056.08
380.36K
Feb 26 - Feb 27
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Nov 27
Form 4
—
0
—
—
0
Nov 15
Form 4
—
0
—
—
0
Oct 31
Form 4
—
0
—
—
0
Oct 15
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Sep 13
Form 4
—
0
—
—
0
Aug 30
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Jul 31
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Apr 30
Form 4
—
0
—
—
0
Apr 15
Form 4
—
0
—
—
0
Mar 28
Form 4
—
0
—
—
0
Mar 15
Form 4
-9.12%
-30.58K
$28.11
-$859,797.83
304.92K
Mar 6
Form 4
+23.62%
64.11K
$27.37
-$891,304.05
335.5K
Feb 28
Form 4
—
0
—
—
0
Dec 28
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Nov 30
Form 4
—
0
—
—
0
Nov 15
Form 4
—
0
—
—
0
Oct 31
Form 4
—
0
—
—
0
Oct 15
Form 4
—
0
—
—
0
Sep 28
Form 4
—
0
—
—
0
Sep 14
Form 4
—
0
—
—
0
Aug 31
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Jul 31
Form 4
—
0
—
—
0
Jul 13
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Apr 30
Form 4
—
0
—
—
0
Apr 13
Form 4
—
0
—
—
0
Mar 30
Form 4
+19.17%
42.41K
—
—
263.63K
Feb 23
Form 4
+47.42%
68.29K
—
—
212.3K
Feb 24
Form 4
+35.58%
36.21K
—
—
137.99K
Feb 25
Form 4
∞
99.82K
—
—
99.82K
Oct 30
Form 3
—
0
—
—
0
No matching records found

Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $0.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Mar 31
Form 3
—
0
—
—
0
No matching records found

WYETH No price found

Sr. VP & Pres., Wyeth Research

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 15
Form 4
—
0
—
—
0
Jun 16
Form 3
—
0
—
—
0
No matching records found

ROCKET PHARMACEUTICALS, INC. (RCKT) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 9
Form 3
—
0
—
—
0
No matching records found